A Pathology Workshop will be held at the Breast Cancer Trials (BCT) 42nd Annual Scientific Meeting (ASM), which is open to all Pathologists and BCT Members.
Increasingly for triple negative and HER2 positive breast cancer, neoadjuvant therapy is considered a standard of care as recommended by international guidelines.
At the recent San Antonio Breast Cancer Symposium, a multi-centre pooled analysis regarding the prognostic importance of Residual Cancer Burden (RCB) after neoadjuvant therapy for overall survival was presented by Fraser Symmans, breast pathologist from MD Anderson.
As neoadjuvant clinical trials that BCT participates in may increasingly require RCB reporting, we have invited Fraser Symmans to attend the Breast Cancer Trials Annual Scientific Meeting (ASM) and present at the Pathology Workshop.
Professor Symmans is the Director of Research Operations in the Department of Pathology at M.D. Anderson Cancer Center, where he practices Breast Surgical Pathology and Cytopathology and directs the Breast Cancer Pharmacogenomics Laboratory.
In addition, the Pathology Workshop will include a talk from Professor Roberto Salgado, who has been driving the assessment of Tumour Infiltrating Lymphocytes (TILs) in Breast Cancer. Professor Salgado is an Anatomic Pathologist in Antwerp, Belgium. He is an honorary Research Associate at the Division of research at the Peter MacCallum Cancer Centre, Melbourne, as well as being part of the Tracer-X Consortium.
Other speakers include Dr Amy McCart Reed, UQ Centre for Clinical Research, who will talk about the implementation of Whole Genome Sequencing pipelines for Breast Cancer, which has recently been funded through the MRFF Genomics Initiative and Mr Heath Badger will provide information on the status of the BCT tissue biobank and upcoming tissue utilisation projects.
The Pathology Workshop is open to Pathologists and BCT members only.
It will be held online from 12.00pm to 2.30pm on Wednesday 28 July 2021.
To register for this workshop, check the ‘Pathology Workshop’ box on the Sessions page when you register for the 42nd Annual Scientific Meeting.